k.batista
TL2 · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 3 September 2025 · last posted 8d
81 posts, newest first. Showing up to 150.
-
Private prescribing in the UK: what is actually involved Replied, post #70 · Regional › UK & Ireland · 20 Jul 2026 · 27 likes I had written a reply contradicting post #67 and deleted it. Here is what survived. The most useful reply I ever got about private prescribing was a request to state my…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #17 · Start Here › How to Ask · 18 Jul 2026 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Spreadsheets: an appreciation — what changed since Replied, post #97 · Lounge › Off topic · 11 Jul 2026 · 24 likes An update on my earlier Spreadsheets post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Asking a follow-up: new topic or new reply? Replied, post #39 · Start Here › How to Ask · 5 Jul 2026 · 27 likes Post #35 and I disagree about the size of the effect, not about the direction. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #53 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes Narrowing post #52, because the general version has more than one answer. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains…
-
Revisiting: The best-written scientific paper you have read Replied, post #53 · Lounge › Off topic · 26 Jun 2026 · 3 likes One caution on best-written scientific paper: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #79 · Start Here › Welcome · 21 Jun 2026 · 25 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Micronutrient adequacy at low total intake Replied, post #68 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 3 likes Adding the measurement that post #67 says would settle it. Temperature and texture change what is tolerable for a lot of people during the first weeks, and that is…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #8 · Practice › Storage & stability · 5 Jun 2026 · 3 likes Reconstituted material carried in a bag for a day is a temperature excursion even in a cool climate. Where that matters is cumulative exposure over weeks rather than a…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #19 · Sourcing › Red flags · 3 Jun 2026 · 2 likes Adding the measurement that post #18 says would settle it. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #48 · Practice › Storage & stability · 1 Jun 2026 · 9 likes Answering the Mean kinetic temperature question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #17 · Compounds › Secretagogues & GH axis · 30 May 2026 · 24 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #55 · Practice › Reconstitution · 22 May 2026 · 6 likes 5 mg vial looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Reading a trial's population section before its results Replied, post #27 · Evidence › Trials · 17 May 2026 · 0 likes Picking up post #24: that is the part I would want checked first. An open-label trial is not worthless and its subjective endpoints deserve more scepticism than its…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #15 · Practice › Dosing & titration · 14 May 2026 · 6 likes Picking up post #14: that is the part I would want checked first. Escalating before steady state means you are judging a dose you have not yet fully experienced. That…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #127 · Practice › Reconstitution · 26 Apr 2026 · 12 likes Adding the measurement that post #126 says would settle it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #6 · Analytics › Mass spectrometry · 23 Apr 2026 · 0 likes Taking post #3 at face value and following it one step further. A definition problem is doing most of the work in this 2 ppm match discussion. Once the term is pinned…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #18 · Practice › Reconstitution · 18 Apr 2026 · 22 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. A single…
-
List price versus negotiated price versus what you pay Replied, post #74 · Access › Pricing · 14 Apr 2026 · 24 likes Where a price is quoted per vial, the fill has to be stated for the comparison to mean anything.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #63 · Start Here › Welcome · 7 Apr 2026 · 0 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #74 · Practice › Reconstitution · 24 Mar 2026 · 14 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #31 · Lounge › Introductions · 10 Mar 2026 · 0 likes Glad to see another member from outside the usual regions. The access and regional categories are thin for anywhere that is not the UK, EU or North America, and a dated…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 25 Feb 2026 · 9 likes This follows post #25 rather than contradicting it. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #52 · Data & Tools › Calculators · 20 Feb 2026 · 30 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #47 · Research Methods › N-of-1 designs · 19 Feb 2026 · 16 likes I read post #45 twice before replying, because I had assumed the opposite. The interesting personal experiments are the ones where the answer was no. They are also the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #64 · Start Here › How to Ask · 16 Feb 2026 · 25 likes Thank you for taking the time. That was more work than a reply usually is.
-
Journal club: orforglipron phase 2 and the non-peptide question Started this topic · Evidence › Journal club · 12 Feb 2026 · 27 likes Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2,…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #11 · Analytics › Mass spectrometry · 12 Feb 2026 · 1 like Adding the measurement that post #10 says would settle it. The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous expression for higher…
-
Aggregates and why a purity assay may miss them entirely Replied, post #53 · Analytics › Impurities & related substances · 6 Jan 2026 · 0 likes This follows post #50 rather than contradicting it. Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method…
-
Impurity thresholds: where the common numbers come from — what changed since Replied, post #2 · marked as the solution · Analytics › Impurities & related substances · 30 Dec 2025 · 17 likes An impurity profile that changes between lots is more informative than the total. A stable profile suggests a controlled process; a shifting one suggests something is…
-
Waist circumference technique and its repeatability Replied, post #32 · Outcomes › Progress reports · 29 Dec 2025 · 28 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #5 · Practice › Reconstitution · 7 Dec 2025 · 4 likes Everything in post #3 holds. The case it does not cover is the one I have. Two people in this thread mean different things by reconstitution volumes and are disagreeing…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #104 · Compounds › Other compounds · 26 Nov 2025 · 15 likes Taking post #103 at face value and following it one step further. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #60 · Analytics › Home & field testing · 22 Nov 2025 · 5 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
An inter-laboratory comparison on one lot, tabulated Replied, post #4 · Analytics › Method validation · 8 Oct 2025 · 6 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 24 likes Post #56 answers the question as asked. The question underneath it is different. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #47 · Data & Tools › Datasets · 8 Sep 2025 · 1 like Coming back to post #45, because the follow-up matters more than the original answer. How to contribute: if you have longitudinal data you want to add, the format is…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #11 · Evidence › Journal club · 3 Sep 2025 · 0 likes The claim about step-hfpef and symptom endpoints upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Started this topic · Compounds › Semaglutide · 22 Aug 2025 · 22 likes Semaglutide half-life: where the 165 to 184 hour figure comes from — setting out what I have, and where I think it stops being reliable. Putting the numbers in the…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #7 · Compounds › Semaglutide · 11 Aug 2025 · 2 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
How to research a compound with no human data without deceiving yourself Replied, post #27 · Compounds › Other compounds · 31 Jul 2025 · 6 likes Confirming post #24 from a second method, which matters more than confirming it from a second person. Research-use-only status is a legal classification, not a safety…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #91 · Compounds › Semaglutide · 28 Jul 2025 · 0 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #11 · Compounds › Secretagogues & GH axis · 25 Jul 2025 · 10 likes Post #8 is right about the mechanism and I think understates the practical bit. A mass result for a short peptide is more discriminating than for a long one, because a…
-
What this community means by "a source", in practical terms Replied, post #30 · Start Here › Welcome · 10 Jul 2025 · 24 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #61 · Compounds › Repair & healing peptides · 7 Jul 2025 · 7 likes Worth separating two things that post #58 runs together. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #41 · Sourcing › Regulatory · 4 Jul 2025 · 30 likes Compound being unapproved: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #78 · Practice › Storage & stability · 3 Jul 2025 · 8 likes The reason published stability data actually covers is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #15 · Practice › Reconstitution · 22 Jun 2025 · 6 likes Second-hand on decimal-point error, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Triple agonism: additive, synergistic, or neither? Replied, post #55 · Compounds › Retatrutide · 10 Jun 2025 · 2 likes Building on post #52 rather than restating it. I have no financial interest in anything named in this thread and I want to say so before I comment on triple agonism,…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #129 · Practice › Reconstitution · 8 Jun 2025 · 0 likes The documentation on 5 mg vial is better than this thread and I say that as someone who has posted in the thread.
-
Half-life, steady state, and accumulation worked through Replied, post #71 · Pharmacology › Pharmacokinetics · 5 Jun 2025 · 0 likes The version of half-life that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #18 · Clinical › Bloodwork · 21 May 2025 · 29 likes Where I part company with post #16, and it is a narrow parting. Hba1c lag was covered in the wiki last year and the page has a review date on it, which is a better…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #4 · Compounds › Secretagogues & GH axis · 20 May 2025 · 22 likes The opening post and I disagree about the size of the effect, not about the direction. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Pregnancy as an absolute contraindication Replied, post #86 · Safety › Contraindications · 20 May 2025 · 19 likes This follows post #85 rather than contradicting it. Marking my uncertainty on pregnancy explicitly. I am confident about the direction, much less confident about the…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 18 May 2025 · 0 likes Narrowing post #16, because the general version has more than one answer. The honest summary of the evidence base: a coherent mechanism, good phase 2 data in…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #40 · Data & Tools › Calculators · 29 Apr 2025 · 1 like Post #39 is right about the mechanism and I think understates the practical bit. Precision and significant figures: the calculators do not round to match your input…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #52 · Evidence › Journal club · 19 Apr 2025 · 7 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #11 · Compounds › Oral incretins · 28 Mar 2025 · 25 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Taking the oral product with more water than instructed reduces absorption rather…
-
A supplier that answers analytical questions with restated claims Replied, post #43 · Sourcing › Red flags · 21 Mar 2025 · 8 likes Taking post #42 at face value and following it one step further. Keep the two claims separate. "The result on this lot did not match the certificate" is a report that…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #38 · Documentation › Doc review · 27 Feb 2025 · 28 likes Answering the question post #34 raises rather than the one it answers. Check the arithmetic in every worked example by hand. A wrong worked example is worse than no…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #8 · Wellbeing › Mental health · 19 Feb 2025 · 0 likes I think the history of disordered eating question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Canadian access and provincial variation Replied, post #79 · Regional › North America · 11 Feb 2025 · 28 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #83 · Data & Tools › Calculators · 9 Feb 2025 · 25 likes Post #81 put the caveat in the right place and I want to underline it. Nothing a calculator produces is medical advice, and a correct calculation on inappropriate…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #20 · Compounds › Oral incretins · 4 Jan 2025 · 12 likes Everything in post #16 holds. The case it does not cover is the one I have. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and…
-
Isotonicity and what happens when you get it wrong Replied, post #13 · Pharmacology › Formulation chemistry · 31 Dec 2024 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Osmolality of a home-reconstituted preparation is whatever the diluent makes it, and nobody…
-
What we do not know about retatrutide, listed explicitly Replied, post #37 · Compounds › Retatrutide · 29 Dec 2024 · 2 likes Post #34 answers the question as asked. The question underneath it is different. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #14 · Analytics › Mass spectrometry · 29 Dec 2024 · 15 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. The honest summary of what a mass result buys you: it narrows the field of what the…
-
Body image changing more slowly than the body Replied, post #129 · Wellbeing › Mental health · 25 Dec 2024 · 0 likes The arithmetic in post #128 is right; the assumption feeding it is the part to check. Motivation and expectation: starting with clear motivation and realistic…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #50 · Sourcing › Regulatory · 24 Dec 2024 · 0 likes Answering the question post #46 raises rather than the one it answers. I would rather this thread reach "we do not know" about Research-use-only labelling than reach a…
-
Converting between mg/mL and units per dose, both directions Replied, post #140 · Practice › Reconstitution · 21 Dec 2024 · 1 like Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Criticising the method without criticising the authors Replied, post #24 · Evidence › Study critique · 15 Dec 2024 · 7 likes Post #21 is the version of this I will quote in future. One addition. An update on my earlier criticising the method without criticising post: the pattern held for…
-
Revisiting: Moderation log format change Replied, post #65 · Meta › Announcements · 12 Dec 2024 · 3 likes I read post #61 twice before replying, because I had assumed the opposite. Second-hand on Moderation log format change, so weight it accordingly — someone whose method…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #2 · Compounds › Other compounds · 30 Nov 2024 · 3 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Time to steady state after a dose increase Replied, post #141 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #2 · Clinical › Comorbidities · 7 Oct 2024 · 15 likes Where I part company with the opening post, and it is a narrow parting. The practical value of this subcategory is helping somebody frame the question they take to an…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #76 · Clinical › Bloodwork · 3 Oct 2024 · 4 likes Where the bring a laboratory discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #31 · Compounds › Retatrutide · 11 Sep 2024 · 17 likes Worth separating two things that post #27 runs together. The question underneath hepatic effects of glucagon receptor is usually "how would I tell?" rather than "what…
-
How to ask for a dose change without antagonising anyone Replied, post #21 · Clinical › Prescriber conversations · 2 Sep 2024 · 5 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #30 · Sourcing › Independent verification · 1 Sep 2024 · 27 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot. I have kept the units in…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #3 · Clinical › Special populations · 26 Aug 2024 · 5 likes Worth separating two things that the opening post runs together. Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact…
-
Assessing a warm arrival: the decision process — one year on Replied, post #107 · Sourcing › Logistics · 1 Jun 2024 · 1 like I came in to disagree and I am leaving without a disagreement.